Mullins v. Pfizer, Inc.

828 F. Supp. 139, 8 I.E.R. Cas. (BNA) 1329, 1993 U.S. Dist. LEXIS 10617, 64 Empl. Prac. Dec. (CCH) 43,084, 62 Fair Empl. Prac. Cas. (BNA) 1007, 1993 WL 286799
CourtDistrict Court, D. Connecticut
DecidedJune 30, 1993
DocketCiv. 2:90CV00917 (AHN)
StatusPublished
Cited by4 cases

This text of 828 F. Supp. 139 (Mullins v. Pfizer, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mullins v. Pfizer, Inc., 828 F. Supp. 139, 8 I.E.R. Cas. (BNA) 1329, 1993 U.S. Dist. LEXIS 10617, 64 Empl. Prac. Dec. (CCH) 43,084, 62 Fair Empl. Prac. Cas. (BNA) 1007, 1993 WL 286799 (D. Conn. 1993).

Opinion

RULING ON DEFENDANT’S MOTION FOR SUMMARY JUDGMENT

NEVAS, District Judge.

This is a five count employment discrimination action brought by James Mullins *142 (“Mullins”) against Ms former employer, Pfizer, Ine. (“Pfizer”). The action arises from allegations that Mullins was constructively discharged and fraudulently induced into accepting early retirement. Specifically, the amended complaint alleges: (1) a deprivation of retirement benefits in violation of the Employment Retirement Income Security Act (“ERISA”), 29 U.S.C. 29 U.S.C. § 1140; (2) a violation of the Age Discrimination in Employment Act, 29 U.S.C. § 621 et seq. (“ADEA”) and (3) claims of wrongful discharge, breach of contract, and breach of covenant of good faith under Connecticut law. Currently pending is defendant’s motion for summary judgment. For the reasons stated below, the court GRANTS Pfizer’s motion for summary judgment.

Standard of Review

In a motion for summary judgment, the moving party bears the burden of establishing that no genuine issues of material fact are in dispute and that it is entitled to judgment as a matter of law. Fed.R.Civ.P. 56(e); Anderson v. Liberty Lobby, Inc. 477 U.S. 242, 256, 106 S.Ct. 2505, 2514, 91 L.Ed.2d 202 (1986). Rule 56(c) mandates summary judgment “after adequate time for discovery and upon motion, against a party who fails to make a showing sufficient to establish the existence of an essential element to that party’s ease, and on wMch the party will bear the burden of proof at trial.” Celotex Corp. v. Catrett, 477 U.S. 317, 322, 106 S.Ct. 2548, 2552, 91 L.Ed.2d 265 (1986). All factual inferences are drawn in favor of the non-moving party. Ramseur v. Chase Manhattan Bank, 865 F.2d 460, 465 (2d Cir.1989).

Facts

Applying these rules, the court finds the following facts undisputed.

1. On April 1,1990, Mullins left his job as a laboratory development technician in Pfizer’s Clarification Division. At the time, Mullins was 57 years-old, and had been employed by Pfizer for approximately 34 years, the last ten at the Clarification Division.

2. In 1987, Martin Kimiatek (“Kimiatek”) became Mullins’ supervisor. Kimiatek was responsible for enforcing Pfizer’s attendance policy. The attendance policy provided no system of earned sick days and sought to minimize unanticipated and/or unplanned absences.

3. During the period from 1988 through 1989, Mullins received three verbal warnings, one written warning, and a one day suspension pursuant to the attendance policy. As of February 27, 1989, Mullins was required to document medical absences with a doctor’s note.

4. Mullins contacted Kimiatek’s supervisors concerning his displeasure over Kimiatek’s enforcement of the attendance policy.

5. In March of 1989, pursuant to Mullins’ request, Pfizer notified Mullins that his early retirement papers were ready.

6. On April 1, 1990, Mullins signed an early retirement form and terminated Ms employment with Pfizer.

7. On May 16, 1990, after Mullins was no longer a Pfizer employee, Pfizer announced and published a Voluntary Separation Option program (the “VSO”) for its employees.

8. The VSO included coordinated release dates between August 6,1990, and December 1, 1990, for all individuals who entered the program. Under the VSO, enrolled employees would receive benefits calculated individually based on their length of service, pension status, and used vacation days status. The VSO also included increased eligibility for medical, dental, and life insurance coverage for employees who were not vested in their pensions for an additional 12 month period following termination or until employed by another organization and eligible for coverage under another group. Participating employees were eligible for up to $4,000 in education assistance for a 24 month period to provide additional retraining to enhance their employability.

9. Prior to the announcement of the VSO, the VSO was under consideration by Pfizer as of February, 1990. It was Pfizer’s policy to deny any rumor concerning the offering of the VSO until it officially announced the plan. On February 9, 1990, in response to rumors that the plan was in the offing, Pfizer announced to its employees that it was not *143 considering offering an increased lump sum severance plan in the foreseeable future.

Discussion

As a preliminary matter, the court notes that the complaint is unclear as to the theories of liability that underlie the various claims and the specific relief Mullins seeks for each. A liberal reading of the complaint, however, suggests that Mullins’ action is two pronged. First, the complaint appears to set forth a claim of constructive discharge based on age discrimination in violation of the ADEA. In support of this claim, Mullins alleges that Pfizer’s selective enforcement of its attendance policy and its denial of its intention to offer the VSO severance package harassed and induced him into taking early retirement. Second, Mullins appears to set forth a claim for lost benefits suffered as a result of the fact that he left Pfizer 46 days prior to the company’s announcement of increased severance benefits under the VSO. In support of the claim for lost severance benefits, Mullins puts forth alternative theories of liability: an ERISA claim under section 1140 in count one and a plethora of state law causes of action in counts three through five. Significantly, all of the claims in this case derive from the underlying allegation that Mullins was constructively discharged.

In response, the crux of Pfizer’s summary judgment motion challenges the sufficiency of Mullins’ allegation of constructive discharge. Pfizer insists that the record fails to support a claim of constructive discharge as a matter of law. Pfizer argues that the voluntary nature of Mullins’ retirement is dispositive of all claims in this case. In the alternative, Pfizer contends that even if the court finds sufficient evidence to support a claim of constructive discharge at this stage of the proceedings, Mullins’ claims for lost benefits under either ERISA or state law are not actionable. Accordingly, the court takes up the sufficiency of the constructive discharge allegation before proceeding to evaluate the specific ADEA, ERISA and state law claims.

A. Constructive Discharge

Pfizer argues that Mullins’ termination was at his own behest when he voluntarily took early retirement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
828 F. Supp. 139, 8 I.E.R. Cas. (BNA) 1329, 1993 U.S. Dist. LEXIS 10617, 64 Empl. Prac. Dec. (CCH) 43,084, 62 Fair Empl. Prac. Cas. (BNA) 1007, 1993 WL 286799, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mullins-v-pfizer-inc-ctd-1993.